Efficacy of defensins as neutralizing agents against the deadly SARS-CoV-2.

Deepthi, Varughese; Mohanakumar, Kochupurackal P; Rajamma, Usha

Deepthi, Varughese; Mohanakumar, Kochupurackal P; Rajamma, Usha.

Afiliação

Deepthi V; Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Speciality Hospital, Mahatma Gandhi University Campus at Thalappady, Kerala, India.
Mohanakumar KP; Centre for Development and Aging Research, Inter University Centre for Biomedical Research & Super Speciality Hospital, Mahatma Gandhi University Campus at Thalappady, Kerala, India.
Rajamma U; Virus Research and Diagnostic Centre, Inter University Centre for Biomedical Research & Super Speciality Hospital, Mahatma Gandhi University Campus at Thalappady, Kerala, India.

J Biomol Struct Dyn ; 41(7): 2911-2925, 2023 04.

Article em En | MEDLINE | ID: mdl-35189779

Assuntos

COVID-19; SARS-CoV-2; Humanos; Enzima de Conversão de Angiotensina 2; Simulação de Acoplamento Molecular; Antivirais; Simulação de Dinâmica Molecular; Defensinas

Palavras-chave

COVID-19 treatment; angiotensin-II converting enzyme; defensin; in-silico study; phytochemicals; spike-protein

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article